Gains May Be On The Menu For Ingredion Inc (NYSE: INGR)

Currently, there are 65.10M common shares owned by the public and among those 64.57M shares have been available to trade.

The company’s stock has a 5-day price change of 3.29% and -0.30% over the past three months. INGR shares are trading -1.78% year to date (YTD), with the 12-month market performance up to 22.72% higher. It has a 12-month low price of $107.20 and touched a high of $155.44 over the same period. INGR has an average intraday trading volume of 485.11K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.66%, -5.09%, and 5.30% respectively.

Institutional ownership of Ingredion Inc (NYSE: INGR) shares accounts for 87.73% of the company’s 65.10M shares outstanding.

It has a market capitalization of $8.80B and a beta (3y monthly) value of 0.74. The stock’s trailing 12-month PE ratio is 13.18, while the earnings-per-share (ttm) stands at $10.25. The company has a PEG of 1.20 and a Quick Ratio of 1.69 with the debt-to-equity ratio at 0.47. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.64% over the week and 1.61% over the month.

Earnings per share for the fiscal year are expected to increase by 12.14%, and 5.66% over the next financial year. EPS should grow at an annualized rate of 11.00% over the next five years, compared to 9.24% over the past 5-year period.

Looking at the support for the INGR, a number of firms have released research notes about the stock. Barclays stated their Overweight rating for the stock in a research note on August 09, 2024, with the firm’s price target at $122-$145. Goldman coverage for the Ingredion Inc (INGR) stock in a research note released on February 15, 2024 offered a Buy rating with a price target of $135. Oppenheimer was of a view on September 29, 2023 that the stock is Outperform, while BMO Capital Markets gave the stock Market Perform rating on April 14, 2023, issuing a price target of $115. UBS on their part issued Buy rating on April 13, 2023.

Most Popular

Related Posts